ENSC · Ensysce Biosciences, Inc.
$0.26
+0.00 (+0.08%)
At close · Jul 27
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These matters, among others, raise substantial doubt about the Company’s ability to continue as a going concern.”View the 10-Q filed May 15, 2026
Market Cap
$3.84M
Shares
14.69M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2025-04-25 | New | Other Health Care | $2,200,012 | $2,200,012 | 06b |
| 2025-04-14 | New | Other Health Care | $1,100,000 | $1,100,000 | 06b |
| 2024-09-12 | New | Other Health Care | $5,055,648 | $5,055,648 | 06b |
| 2024-02-21 | New | Other Health Care | $4,718,295 | $4,718,295 | 06b |
| 2023-03-01 | New | Other Health Care | $2,816,073 | $2,816,073 | 06b |
| 2022-07-08 | New | Other Health Care | $8,480,000 | $4,240,000 | 06b |
| 2021-10-06 | New | Other Health Care | $15,900,000 | $5,300,000 | 06b |
Showing 1–7 of 7 filings